149 related articles for article (PubMed ID: 15806571)
21. Disialoganglioside directed immunotherapy of neuroblastoma.
Modak S; Cheung NK
Cancer Invest; 2007 Feb; 25(1):67-77. PubMed ID: 17364560
[TBL] [Abstract][Full Text] [Related]
22. A combined HIV-1 protein bead array for serology assay and T-cell subset immunophenotyping with a hybrid flow cytometer: a step in the direction of a comprehensive multitasking instrument platform for infectious disease diagnosis and monitoring.
Faucher S; Martel A; Sherring A; Bogdanovic D; Malloch L; Kim JE; Bergeron M; Sandstrom P; Mandy FF
Cytometry B Clin Cytom; 2006 May; 70(3):179-88. PubMed ID: 16615079
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy with GD2 specific monoclonal antibodies.
Cheung NK; Medof ME; Munn D
Prog Clin Biol Res; 1988; 271():619-32. PubMed ID: 3043454
[No Abstract] [Full Text] [Related]
24. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
Riemer AB; Förster-Waldl E; Brämswig KH; Pollak A; Zielinski CC; Pehamberger H; Lode HN; Scheiner O; Jensen-Jarolim E
Eur J Immunol; 2006 May; 36(5):1267-74. PubMed ID: 16568495
[TBL] [Abstract][Full Text] [Related]
25. Total nucleated cell differential for blood and bone marrow using a single tube in a five-color flow cytometer.
Björnsson S; Wahlström S; Norström E; Bernevi I; O'Neill U; Johansson E; Runström H; Simonsson P
Cytometry B Clin Cytom; 2008 Mar; 74(2):91-103. PubMed ID: 18061952
[TBL] [Abstract][Full Text] [Related]
26. Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma.
Otto M; Barfield RC; Martin WJ; Iyengar R; Leung W; Leimig T; Chaleff S; Gillies SD; Handgretinger R
Clin Cancer Res; 2005 Dec; 11(23):8486-91. PubMed ID: 16322312
[TBL] [Abstract][Full Text] [Related]
27. Cell-surface ganglioside GD2 in the immunohistochemical detection and differential diagnosis of neuroblastoma.
Sariola H; Terävä H; Rapola J; Saarinen UM
Am J Clin Pathol; 1991 Aug; 96(2):248-52. PubMed ID: 1713742
[TBL] [Abstract][Full Text] [Related]
28. Structural characterization and in vivo immunosuppressive activity of neuroblastoma GD2.
Li R; Gage D; McKallip R; Ladisch S
Glycoconj J; 1996 Jun; 13(3):385-9. PubMed ID: 8781969
[TBL] [Abstract][Full Text] [Related]
29. Dual-labelled antibodies for flow and mass cytometry: A new tool for cross-platform comparison and enrichment of target cells for mass cytometry.
Baumgart S; Schulz AR; Peddinghaus A; Stanislawiak S; Gillert S; Hirseland H; Krauthäuser S; Dose C; Mei HE; Grützkau A
Eur J Immunol; 2017 Aug; 47(8):1377-1385. PubMed ID: 28654217
[TBL] [Abstract][Full Text] [Related]
30. Novel use of the BD FACS SPA to automate custom monoclonal antibody panel preparations for immunophenotyping.
Kelliher AS; Parent DW; Anderson DC; Dorn ME; Hahn JL; Eapen S; Preffer FI
Cytometry B Clin Cytom; 2005 Jul; 66(1):40-5. PubMed ID: 15918157
[TBL] [Abstract][Full Text] [Related]
31. Overview and application of suspension array technology.
Mandy FF; Nakamura T; Bergeron M; Sekiguchi K
Clin Lab Med; 2001 Dec; 21(4):713-29, vii. PubMed ID: 11770283
[TBL] [Abstract][Full Text] [Related]
32. Clinical Cytometry on both sides of the Atlantic, 2011.
Preffer FI; Gratama JW
Cytometry B Clin Cytom; 2011 Nov; 80(6):373-4. PubMed ID: 22002905
[No Abstract] [Full Text] [Related]
33. 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.
Cheung NK; Kushner BH; Yeh SD; Larson SM
Int J Oncol; 1998 Jun; 12(6):1299-306. PubMed ID: 9592190
[TBL] [Abstract][Full Text] [Related]
34. Automated analysis in flow cytometry.
Cualing HD
Cytometry; 2000 Apr; 42(2):110-3. PubMed ID: 10797448
[No Abstract] [Full Text] [Related]
35. Quantitative flow cytometry.
Schwartz A; Fernández-Repollet E
Clin Lab Med; 2001 Dec; 21(4):743-61. PubMed ID: 11770285
[TBL] [Abstract][Full Text] [Related]
36. Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases.
Fest S; Huebener N; Weixler S; Bleeke M; Zeng Y; Strandsby A; Volkmer-Engert R; Landgraf C; Gaedicke G; Riemer AB; Michalsky E; Jaeger IS; Preissner R; Förster-Wald E; Jensen-Jarolim E; Lode HN
Cancer Res; 2006 Nov; 66(21):10567-75. PubMed ID: 17079481
[TBL] [Abstract][Full Text] [Related]
37. The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma.
Lovat PE; Corazzari M; Di Sano F; Piacentini M; Redfern CP
Cancer Lett; 2005 Oct; 228(1-2):105-10. PubMed ID: 15907365
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotyping.
Stewart CC; Stewart SJ
Curr Protoc Cytom; 2001 May; Chapter 6():Unit 6.2. PubMed ID: 18770715
[TBL] [Abstract][Full Text] [Related]
39. Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies.
Ruiz-Argüelles A; Rivadeneyra-Espinoza L; Duque RE; Orfao A;
Cytometry B Clin Cytom; 2006 Jan; 70(1):39-44. PubMed ID: 16353215
[TBL] [Abstract][Full Text] [Related]
40. Analyzing B cell chronic lymphocytic leukemia with Oncomark tubes on a FACSCanto.
Warzynski MJ; Rawlings PL
Cytometry B Clin Cytom; 2007 Sep; 72(5):418-22. PubMed ID: 17226864
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
